Shuttle Pharmaceuticals Holdings (SHPH) Cash from Investing Activities (2023 - 2026)

Shuttle Pharmaceuticals Holdings' Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$36000.0 for Q1 2026.

• In Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$36000.0; the TTM figure through Mar 2026 stood at $2.8 million (changed N/A YoY), while the FY2025 annual figure was -$3.1 million, down 204.83% from the prior year.
• Cash from Investing Activities was -$36000.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from $1.7 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $1.7 million in Q3 2024 to a low of -$3.0 million in Q1 2023.
• Historically, Cash from Investing Activities has averaged $6255.2 across 3 years, with a median of $74920.5 in 2023.
• Biggest YoY gain for Cash from Investing Activities was 6506.87% in 2024; the steepest drop was 103.43% in 2024.
• A 3-year view of Cash from Investing Activities shows it stood at $87037.0 in 2023, then soared by 1803.21% to $1.7 million in 2024, then plunged by 102.17% to -$36000.0 in 2026.
• The last three Cash from Investing Activities figures came in at -$36000.0 (Q1 2026), $1.7 million (Q3 2024), and $1.2 million (Q2 2024), per Business Quant data.